With room-temperature kit storage and shipping, Illumina's newest sequencers remove barriers to enable more insights and discoveries SAN DIEGO, Oct. 9, 2024 /PRNewswire/ -- Illumina, Inc. (ILMN), a ...

San Diego-based Illumina, a global leader in genomic sequencing technology, unveiled its latest machines that could make analyzing genetics cheaper, more efficient and more accessible to researchers.

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...

The U.S. government has sounded the alarm about a critical software vulnerability found in genomics giant Illumina’s DNA sequencing devices, which hackers can exploit to modify or steal patients’ ...

The Illumina MiSeq stands out as a robust desktop sequencing system ideal for targeted applications such as amplicon sequencing, small genome sequencing, metagenomics, miRNA-seq, targeted gene ...

The FDA issued a letter noting that nearly the entire Illumina Inc's (NASDAQ:ILMN) sequencer lineup carries a cybersecurity vulnerability that could impact genomic data results or even result in a ...

Next-generation sequencing (NGS) has moved away from expensive runs and complicated workflows into a new era where benchtop instruments prioritize sustainability, accessibility, accuracy, and speed.

This article is based on a poster originally authored by Dagmara Wanda Lewandowska, PhD, Marc Gasser, PhD, Vanina Haunreiter-Dengler, PhD and Eva Meszaros, PhD, which was presented at ELRIG Drug ...

SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best ...